Carolus H, Pierson S, Muñoz JF, et al. Genome-Wide Analysis of Experimentally Evolved Candida auris Reveals Multiple Novel Mechanisms of Multidrug Resistance. mBio. 2021;12(2). doi:10.1128/mBio.03333-20.

Iyer KR, Camara K, Daniel-Ivad M, et al. An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris. Nat Commun. 2020;11(1):6429. doi:10.1038/s41467-020-20183-3.

Bing J, Hu T, Zheng Q, Muñoz JF, Cuomo CA, Huang G. Experimental Evolution Identifies Adaptive Aneuploidy as a Mechanism of Fluconazole Resistance in Candida auris. Antimicrob Agents Chemother. 2020;65(1). doi:10.1128/AAC.01466-20.

DeJarnette C, Meyer CJ, Jenner AR, et al. Identification of Inhibitors of Fungal Fatty Acid Biosynthesis. ACS Infect Dis. 2021;7(12):3210-3223. doi:10.1021/acsinfecdis.1c00404.

Kim SH, Iyer KR, Pardeshi L, et al. Genetic Analysis of Implicates Hsp90 in Morphogenesis and Azole Tolerance and Cdr1 in Azole Resistance. MBio. 2019;10(1). doi:10.1128/mBio.02529-18.

Muñoz JF, Gade L, Chow NA, et al. Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species. Nat Commun. 2018;9(1):5346. doi:10.1038/s41467-018-07779-6.

McLellan CA, Vincent BM, Solis NV, et al. Inhibiting mitochondrial phosphate transport as an unexploited antifungal strategy. Nat Chem Biol. 2018;14(2):135-141. doi:10.1038/nchembio.2534.

Rybak JM, Muñoz JF, Barker KS, et al. Mutations in TAC1B: a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris. mBio. 2020;11(3). doi:10.1128/mBio.00365-20.

Butcher RA, Bhullar BS, Perlstein EO, Marsischky G, LaBaer J, Schreiber SL. Microarray-based method for monitoring yeast overexpression strains reveals small-molecule targets in TOR pathway. Nat Chem Biol. 2006;2(2):103-9. doi:10.1038/nchembio762.

Nash A, Sewell T, Farrer RA, et al. MARDy: Mycology Antifungal Resistance Database. Bioinformatics. 2018;34(18):3233-3234. doi:10.1093/bioinformatics/bty321.